CAPR logo

CAPR EBITDA

annual EBITDA:

-$42.56M-$19.56M(-84.99%)
December 31, 2024

Summary

  • As of today (July 7, 2025), CAPR annual EBITDA is -$42.56 million, with the most recent change of -$19.56 million (-84.99%) on December 31, 2024.
  • During the last 3 years, CAPR annual EBITDA has fallen by -$21.87 million (-105.70%).
  • CAPR annual EBITDA is now -1531.04% below its all-time high of $2.97 million, reached on December 31, 2017.

Performance

CAPR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCAPRincome statement metrics

quarterly EBITDA:

-$24.58M-$17.26M(-235.66%)
March 31, 2025

Summary

  • As of today (July 7, 2025), CAPR quarterly EBITDA is -$24.58 million, with the most recent change of -$17.26 million (-235.66%) on March 31, 2025.
  • Over the past year, CAPR quarterly EBITDA has dropped by -$14.64 million (-147.40%).
  • CAPR quarterly EBITDA is now -297.88% below its all-time high of $12.42 million, reached on December 31, 2017.

Performance

CAPR quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCAPRincome statement metrics

TTM EBITDA:

-$55.78M-$14.64M(-35.59%)
March 31, 2025

Summary

  • As of today (July 7, 2025), CAPR TTM EBITDA is -$55.78 million, with the most recent change of -$14.64 million (-35.59%) on March 31, 2025.
  • Over the past year, CAPR TTM EBITDA has dropped by -$30.79 million (-123.23%).
  • CAPR TTM EBITDA is now -1975.36% below its all-time high of $2.97 million, reached on December 31, 2017.

Performance

CAPR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCAPRincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CAPR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-85.0%-147.4%-123.2%
3 y3 years-105.7%-217.6%-139.2%
5 y5 years-462.9%-1084.7%-552.0%

CAPR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-105.7%at low-2424.1%at low-142.4%at low
5 y5-year-462.9%at low-2424.1%at low-552.0%at low
alltimeall time-1531.0%at low-297.9%at low-1975.4%at low

CAPR EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$24.58M(+235.7%)
-$55.78M(+35.6%)
Dec 2024
-$42.56M(+85.0%)
-$7.32M(-42.1%)
-$41.14M(+18.2%)
Sep 2024
-
-$12.65M(+12.6%)
-$34.79M(+21.1%)
Jun 2024
-
-$11.23M(+13.1%)
-$28.73M(+15.0%)
Mar 2024
-
-$9.93M(+920.3%)
-$24.99M(+8.6%)
Dec 2023
-$23.01M(-21.1%)
-$973.70K(-85.2%)
-$23.01M(-23.1%)
Sep 2023
-
-$6.59M(-12.1%)
-$29.91M(+0.8%)
Jun 2023
-
-$7.49M(-5.8%)
-$29.66M(+1.0%)
Mar 2023
-
-$7.95M(+1.0%)
-$29.38M(+0.7%)
Dec 2022
-$29.16M(+40.9%)
-$7.87M(+24.2%)
-$29.16M(+5.7%)
Sep 2022
-
-$6.34M(-12.1%)
-$27.59M(+8.2%)
Jun 2022
-
-$7.21M(-6.8%)
-$25.50M(+9.3%)
Mar 2022
-
-$7.74M(+22.8%)
-$23.32M(+12.7%)
Dec 2021
-$20.69M(+52.8%)
-$6.30M(+48.3%)
-$20.69M(+11.7%)
Sep 2021
-
-$4.25M(-15.5%)
-$18.53M(+2.0%)
Jun 2021
-
-$5.03M(-1.6%)
-$18.16M(+9.5%)
Mar 2021
-
-$5.11M(+23.5%)
-$16.58M(+22.4%)
Dec 2020
-$13.55M(+79.1%)
-$4.14M(+6.7%)
-$13.55M(+24.9%)
Sep 2020
-
-$3.88M(+12.2%)
-$10.85M(+26.8%)
Jun 2020
-
-$3.46M(+66.6%)
-$8.56M(+20.1%)
Mar 2020
-
-$2.07M(+44.0%)
-$7.12M(-5.8%)
Dec 2019
-$7.56M(-50.2%)
-$1.44M(-9.1%)
-$7.56M(-19.4%)
Sep 2019
-
-$1.58M(-21.6%)
-$9.38M(-21.3%)
Jun 2019
-
-$2.02M(-19.5%)
-$11.93M(-15.0%)
Mar 2019
-
-$2.51M(-23.0%)
-$14.03M(-7.5%)
Dec 2018
-$15.17M(-610.0%)
-$3.26M(-21.0%)
-$15.17M(-3054.7%)
Sep 2018
-
-$4.13M(+0.2%)
$513.40K(-75.0%)
Jun 2018
-
-$4.12M(+12.9%)
$2.05M(-27.9%)
Mar 2018
-
-$3.65M(-129.4%)
$2.84M(-4.4%)
Dec 2017
$2.97M(-116.2%)
$12.42M(-578.8%)
$2.97M(-121.5%)
Sep 2017
-
-$2.59M(-22.1%)
-$13.83M(-15.9%)
Jun 2017
-
-$3.33M(-5.5%)
-$16.44M(-7.1%)
Mar 2017
-
-$3.52M(-19.6%)
-$17.69M(-3.5%)
Dec 2016
-$18.34M(+46.7%)
-$4.38M(-15.9%)
-$18.34M(+6.6%)
Sep 2016
-
-$5.21M(+13.7%)
-$17.21M(+16.1%)
Jun 2016
-
-$4.58M(+9.8%)
-$14.82M(+11.6%)
Mar 2016
-
-$4.17M(+28.2%)
-$13.28M(+6.2%)
Dec 2015
-$12.50M(+109.2%)
-$3.25M(+15.2%)
-$12.50M(+12.6%)
Sep 2015
-
-$2.82M(-7.0%)
-$11.10M(+13.8%)
Jun 2015
-
-$3.04M(-10.5%)
-$9.75M(+19.1%)
Mar 2015
-
-$3.39M(+82.8%)
-$8.19M(+37.0%)
Dec 2014
-$5.97M(-32.2%)
-$1.85M(+26.0%)
-$5.97M(-28.8%)
Sep 2014
-
-$1.47M(+0.2%)
-$8.39M(-0.5%)
Jun 2014
-
-$1.47M(+24.7%)
-$8.44M(-1.6%)
Mar 2014
-
-$1.18M(-72.4%)
-$8.58M(-2.6%)
Dec 2013
-$8.81M(+329.4%)
-$4.27M(+182.0%)
-$8.81M(+79.8%)
Sep 2013
-
-$1.52M(-5.9%)
-$4.90M(+24.1%)
Jun 2013
-
-$1.61M(+14.5%)
-$3.95M(+106.3%)
Mar 2013
-
-$1.41M(+285.9%)
-$1.91M(+49.9%)
DateAnnualQuarterlyTTM
Dec 2012
-$2.05M(-58.0%)
-$364.70K(-35.4%)
-$1.28M(-50.4%)
Sep 2012
-
-$564.80K(-233.5%)
-$2.57M(-18.3%)
Jun 2012
-
$423.00K(-154.9%)
-$3.15M(-29.2%)
Mar 2012
-
-$770.10K(-53.7%)
-$4.45M(-8.7%)
Dec 2011
-$4.88M(-22.3%)
-$1.66M(+45.6%)
-$4.88M(+14.6%)
Sep 2011
-
-$1.14M(+30.0%)
-$4.26M(-13.6%)
Jun 2011
-
-$878.40K(-26.5%)
-$4.92M(-11.2%)
Mar 2011
-
-$1.20M(+14.9%)
-$5.54M(-11.7%)
Dec 2010
-$6.28M(-18.7%)
-$1.04M(-42.5%)
-$6.28M(-7.5%)
Sep 2010
-
-$1.81M(+20.8%)
-$6.79M(-2.6%)
Jun 2010
-
-$1.50M(-22.5%)
-$6.97M(-12.3%)
Mar 2010
-
-$1.93M(+24.9%)
-$7.95M(+2.9%)
Dec 2009
-$7.72M(-41.9%)
-$1.55M(-22.3%)
-$7.72M(-15.6%)
Sep 2009
-
-$1.99M(-19.5%)
-$9.15M(-12.9%)
Jun 2009
-
-$2.47M(+44.6%)
-$10.50M(-11.4%)
Mar 2009
-
-$1.71M(-42.4%)
-$11.85M(-10.8%)
Dec 2008
-$13.29M(+40.3%)
-$2.97M(-11.2%)
-$13.29M(+2.0%)
Sep 2008
-
-$3.35M(-12.4%)
-$13.02M(-9.0%)
Jun 2008
-
-$3.82M(+21.2%)
-$14.31M(+20.1%)
Mar 2008
-
-$3.15M(+16.6%)
-$11.91M(+25.8%)
Dec 2007
-$9.47M(+279.2%)
-$2.70M(-41.6%)
-$9.47M(+29.1%)
Sep 2007
-
-$4.63M(+225.2%)
-$7.34M(+110.3%)
Jun 2007
-
-$1.42M(+100.1%)
-$3.49M(+69.8%)
Mar 2007
-
-$711.90K(+25.7%)
-$2.05M(+52.2%)
Dec 2006
-$2.50M(>+9900.0%)
-$566.20K(-27.9%)
-$1.35M(+70.7%)
Sep 2006
-
-$785.10K(-8823.3%)
-$790.40K(+8985.1%)
Jun 2006
-
$9000.00(-225.0%)
-$8700.00(-57.8%)
Mar 2006
-
-$7200.00(+1.4%)
-$20.60K(+9.6%)
Dec 2005
-$18.90K(-0.5%)
-$7100.00(+108.8%)
-$18.80K(-14.2%)
Sep 2005
-
-$3400.00(+17.2%)
-$21.90K(-0.5%)
Jun 2005
-
-$2900.00(-46.3%)
-$22.00K(0.0%)
Mar 2005
-
-$5400.00(-47.1%)
-$22.00K(+15.2%)
Dec 2004
-$19.00K(+17.3%)
-$10.20K(+191.4%)
-$19.10K(+33.6%)
Sep 2004
-
-$3500.00(+20.7%)
-$14.30K(+31.2%)
Jun 2004
-
-$2900.00(+16.0%)
-$10.90K(-27.3%)
Mar 2004
-
-$2500.00(-53.7%)
-$15.00K(-7.4%)
Dec 2003
-$16.20K(-9.0%)
-$5400.00(+5300.0%)
-$16.20K(+11.0%)
Sep 2003
-
-$100.00(-98.6%)
-$14.60K(-36.8%)
Jun 2003
-
-$7000.00(+89.2%)
-$23.10K(-16.6%)
Mar 2003
-
-$3700.00(-2.6%)
-$27.70K(+55.6%)
Dec 2002
-$17.80K(-19.8%)
-$3800.00(-55.8%)
-$17.80K(+6.0%)
Sep 2002
-
-$8600.00(-25.9%)
-$16.80K(+30.2%)
Jun 2002
-
-$11.60K(-287.1%)
-$12.90K(+87.0%)
Mar 2002
-
$6200.00(-321.4%)
-$6900.00(-68.9%)
Dec 2001
-$22.20K(-38.8%)
-$2800.00(-40.4%)
-$22.20K(+14.4%)
Sep 2001
-
-$4700.00(-16.1%)
-$19.40K(+32.0%)
Jun 2001
-
-$5600.00(-38.5%)
-$14.70K(+61.5%)
Mar 2001
-
-$9100.00
-$9100.00
Dec 2000
-$36.30K(<-9900.0%)
-
-
Dec 1999
$0.00
-
-

FAQ

  • What is Capricor Therapeutics, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Capricor Therapeutics, Inc.?
  • What is Capricor Therapeutics, Inc. annual EBITDA year-on-year change?
  • What is Capricor Therapeutics, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Capricor Therapeutics, Inc.?
  • What is Capricor Therapeutics, Inc. quarterly EBITDA year-on-year change?
  • What is Capricor Therapeutics, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Capricor Therapeutics, Inc.?
  • What is Capricor Therapeutics, Inc. TTM EBITDA year-on-year change?

What is Capricor Therapeutics, Inc. annual EBITDA?

The current annual EBITDA of CAPR is -$42.56M

What is the all time high annual EBITDA for Capricor Therapeutics, Inc.?

Capricor Therapeutics, Inc. all-time high annual EBITDA is $2.97M

What is Capricor Therapeutics, Inc. annual EBITDA year-on-year change?

Over the past year, CAPR annual EBITDA has changed by -$19.56M (-84.99%)

What is Capricor Therapeutics, Inc. quarterly EBITDA?

The current quarterly EBITDA of CAPR is -$24.58M

What is the all time high quarterly EBITDA for Capricor Therapeutics, Inc.?

Capricor Therapeutics, Inc. all-time high quarterly EBITDA is $12.42M

What is Capricor Therapeutics, Inc. quarterly EBITDA year-on-year change?

Over the past year, CAPR quarterly EBITDA has changed by -$14.64M (-147.40%)

What is Capricor Therapeutics, Inc. TTM EBITDA?

The current TTM EBITDA of CAPR is -$55.78M

What is the all time high TTM EBITDA for Capricor Therapeutics, Inc.?

Capricor Therapeutics, Inc. all-time high TTM EBITDA is $2.97M

What is Capricor Therapeutics, Inc. TTM EBITDA year-on-year change?

Over the past year, CAPR TTM EBITDA has changed by -$30.79M (-123.23%)
On this page